June 11, 2026
No More Needles: AstraZeneca’s Daily Weight-Loss Pill Shows Promising Trial Results
by DitoSaPilipinas.comAstraZeneca has officially moved its experimental drug, elecoglipron, into late-stage trials after mid-stage clinical data revealed that a simple, once-daily pill can deliver double-digit weight loss. According to results published in The Lancet, patients taking the tablet shed an average of 10.5% of their body weight over 26 weeks, with the highest dose increasing this to 11.8% by week 36. Read more »
